Aspire Biopharma Holdings Inc [NASDAQ: ASBP] gained 2.67% or 0.0 points to close at $0.1 with a heavy trading volume of 16041241 shares.
It opened the trading session at $0.0985, the shares rose to $0.1044 and dropped to $0.0955, the range by which the price of stock traded the whole day. The daily chart for ASBP points out that the company has recorded -57.89% loss over the past six months.
If we look at the average trading volume of 33.23M shares, ASBP reached to a volume of 16041241 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Trading performance analysis for ASBP stock
Aspire Biopharma Holdings Inc [ASBP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.53. With this latest performance, ASBP shares dropped by -70.96% in over the last four-week period, additionally sinking by -57.89% over the last 6 months – not to mention a drop of -99.13% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASBP stock in for the last two-week period is set at 27.76, with the RSI for the last a single of trading hit 0.0355, and the three-weeks RSI is set at 0.0482 for Aspire Biopharma Holdings Inc [ASBP]. The present Moving Average for the last 50 days of trading for this stock 0.3015, while it was recorded at 0.1000 for the last single week of trading, and 0.8764 for the last 200 days.
Aspire Biopharma Holdings Inc [ASBP]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Aspire Biopharma Holdings Inc [ASBP] shares currently have an operating margin of -901693.30% and a Gross Margin at 45.54%.
Aspire Biopharma Holdings Inc (ASBP) Capital Structure & Debt Analysis
Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics
Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics
An analysis of Institutional ownership at Aspire Biopharma Holdings Inc [ASBP]
There are presently around $2.86%, or 3.61%% of ASBP stock, in the hands of institutional investors.
